Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
UBS and Citi Are Bullish on Royalty Pharma Plc (RPRX) - Here's Why
Royalty Pharma Plc (NASDAQ: RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30, Royalty Pharma Plc (NASDAQ:RPRX) was upgraded to Buy from Neutral by UBS, with the firm raising the price target on the stock to $49 from…
New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
New to The Street, the nationally syndicated, long-form television and digital media platform, today announced it has signed a six-part media series with Medicus Pharma Ltd. (NASDAQ:MDCX) ('Medicus' or the 'Company'), a precision guided…
OneSource Speciality Pharma receives SFDA approval for its generic Ozempic
OneSource Speciality Pharma announced it has received Saudi Food and Drug Authority (SFDA) approval of its generic Ozempic (semaglutide) in Saudi Arabia, clearing the path for commercialsing the product with Hikma Pharmaceuticals PLC (Hikma) as…
US-Bangladesh pact unlikely to impact India's pharma, medtech exports
The United States and Bangladesh have finalised a bilateral reciprocal trade agreement aimed at deepening economic ties, but industry executives say it is unlikely to materially impact India's pharmaceutical and medical device exports, despite…
Aurobindo Pharma sinks 8%, stock hits over 3-month low post Q3 results
Share price of Aurobindo Pharma hit an over three-month low at ₹1,110.55, falling 8 per cent on the BSE in Tuesday's intra-day trade after the company announced December 2025 quarter (Q3FY26) results on Monday after market hours. The stock…
Ascendis Pharma A/S $ASND Shares Sold by Candriam S.C.A.
Candriam S.C.A. reduced its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 8.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional…
CorMedix Investor Day: Melinta Deal Fuels Shift to Multi-Product Pharma, Rezzayo Q2 Data Ahead
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 CorMedix NASDAQ: CRMD used its 2026 Analyst and Investor Day to outline its shift from a single-product renal-focused company to what management described as a diversified…
Allianz Asset Management GmbH Sells 127,319 Shares of Royalty Pharma PLC $RPRX
Allianz Asset Management GmbH reduced its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 35.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 235,227…
Pearl Global Industries Ltd leads losers in 'A' group
Kiri Industries Ltd, Gokaldas Exports Ltd, Aurobindo Pharma Ltd and Kitex Garments Ltd are among the other losers in the BSE's 'A' group today, 10 February 2026. Kiri Industries Ltd, Gokaldas Exports Ltd, Aurobindo Pharma Ltd and Kitex Garments Ltd…
Here is Why Amcor (AMCR) is Highly Favored by Hedge Funds
Amcor plc (NYSE: AMCR) is one of the 8 best paper and plastic packaging stocks to buy according to hedge funds. On February 4, Ghansham Panjabi at Baird raised his target price on Amcor plc (NYSE:AMCR) from $50 to $54, resulting in a 12% upside.
How Reco raised $30 million and grew an additional 400% last year as companies sprint into AI
New York-based cybersecurity startup Reco has raised $30 million in Series B funding as companies rapidly expand their AI use. Ofer Klein, Gal Nakash, and Tal Shapira founded Reco in 2020 to fill the gap between a company's existing cybersecurity…
AstraZeneca gets regulator's nod to market cancer drug Imfinzi for additional indication
AstraZeneca Pharma India Ltd on Tuesday (February 10, 2026) said it has received permission from India's drug regulator to market Durvalumab solution for infusion used in cancer treatment for an additional indication. The company has received…
Q3 results today: Ashok Leyland, Lenskart, M&M among 344 firms on Feb 11
Ashok Leyland, Mahindra & Mahindra, LG Electronics, Lenskart Solutions, Max Financial, AstraZeneca Pharma, Kirloskar Oil Engines, and Godrej Industries are among 344 firms scheduled to announce their earnings report for the third quarter (Q3FY26)…
Stock Alert: Titan Company, Eicher Motors, Apollo Hospitals Ent, Grasim Industries, Torrent Power
Securities in F&O Ban: Sammaan Capital and Steel Authority of India (SAIL) shares are banned from F&O trading on 11 February 2026. Mahindra & Mahindra, LG Electronics India, Lenskart Solutions, Ashok Leyland, Aarey Drugs & Pharmaceuticals, Amagi…
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
BELFAST, Northern Ireland, Feb. 10, 2026 /CNW/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, has entered the Japanese market…
Receive a Daily briefing on Pharma Industry News
Get Started